Neuropeptide deficits in schizophrenia vs. Alzheimer's disease cerebral cortex
- 1 January 1996
- journal article
- research article
- Published by Elsevier in Biological Psychiatry
- Vol. 39 (2) , 82-91
- https://doi.org/10.1016/0006-3223(95)00066-6
Abstract
No abstract availableKeywords
This publication has 66 references indexed in Scilit:
- The emergence of the cortical GABAergic neuron: with particular reference to some peptidergic subpopulationsJournal of Neurocytology, 1993
- Corticotropin-releasing factor immunoreactive neurons persist throughout the brain in Alzheimer's diseaseBrain Research, 1989
- Ultrastructural analysis of somatostatin‐immunoreactive neurons and synapses in the temporal and occipital cortex of the macaque monkeyJournal of Comparative Neurology, 1989
- Somatostatin and neuropeptide Y are unaltered in the amygdala in schizophreniaNeurochemical Pathology, 1987
- Decreased somatostatin immunoreactivity but not neuropeptide Y immunoreactivity in cerebral cortex in senile dementia of Alzheimer typeNeuroscience Letters, 1986
- II. Cortical neurons immunoreactive with antisera against neuropeptide Y are altered in Alzheimer's‐type dementiaJournal of Comparative Neurology, 1985
- Coexistence of neuropeptide Y and somatostatin in rat and human cortical and rat hypothalamic neuronsNeuroscience Letters, 1984
- A New Clinical Scale for the Staging of DementiaThe British Journal of Psychiatry, 1982
- Normal cortical concentration of cholecystokinin-like immunoreactivity with reduced choline acetyltransferase activity in senile dementia of Alzheimer typeLife Sciences, 1981
- Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia.BMJ, 1978